×
About 7,240 results

ALLMedicine™ Uveitis Center

Research & Reviews  2,385 results

Hydroa vacciniforme-like lymphoproliferative disorder with eye involvement.
https://doi.org/10.1111/pde.14808
Pediatric Dermatology; Feng X, Li F et. al.

Sep 26th, 2021 - Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is characterized by vesiculopapular eruptions on sun-exposed and sometimes unexposed skin. Though ocular involvement in HVLPD is rare, it may present with conjunctivitis, corneal opacit...

Tubulointerstitial nephritis and uveitis syndrome following meningitis and systemic lym...
https://doi.org/10.1186/s13256-021-02909-z 10.1053/j.ajkd.2017.11.013 10.1016/0002-9343(75)90390-3 10.12659/AJCR.892788 10.1016/S0039-6257(01)00261-2 10.1016/j.tmaid.2014.05.007 10.1159/000362688 10.1128/CMR.00057-17 10.1016/S0022-3476(74)80123-X 10.1111/j.1651-2227.1972.tb15866.x.,1972 10.1136/bcr-2018-229159 10.1007/s00467-011-1915-9 10.1186/1752-1947-5-16 10.2217/fmb.09.89 10.1590/s0074-02762009000200039 10.1128/JCM.36.10.2907-2913.1998 10.1016/0163-4453(93)92300-l 10.1111/j.1469-0691.2011.03648.x 10.1128/CVI.05486-11 10.1038/s41598-020-69078-9 10.1371/journal.pntd.0008103 10.1093/clinids/9.5.1055,1987 10.1128/jcm.25.1.100-105.1987 10.1093/infdis/142.5.757,1980 10.1128/jcm.17.6.981-987.1983 10.1128/jcm.27.9.2133-2135.1989 10.1017/S0950268803001948 10.1590/s0036-46652008000400010 10.4274/tpd.galenos.2019.6076 10.1016/j.jiac.2019.01.009 10.1128/JCM.02092-10 10.1016/S0732-8893(98)00077-7 10.1128/JCM.42.3.941-945.2004 10.1007/BF01095961 10.1681/ASN.2006050418 10.2215/CJN.02540313 10.2215/CJN.09051209 10.5414/cn107119 10.1111/j.1398-9995.2004.00547.x 10.1007/s10157-007-0485-4 10.4103/1319-2442.135184 10.1093/ndt/gfg464 10.1007/s10157-008-0069-y 10.1378/chest.07-3088 10.5414/CP203287 10.1038/ki.1989.118 10.1097/MD.0b013e3180699f55,2007 10.1146/annurev.me.29.020178.001203 10.1038/ki.1975.38 10.1159/000231067,1973 10.1056/NEJM197504242921701 10.1007/s00467-016-3394-5 10.1164/ajrccm.164.10.2104046 10.1097/MD.0b013e31819de50f 10.1177/000992289803701201 10.1186/s13023-017-0677-2 10.1016/s0039-6257(97)00130-6 10.1007/s00247-008-1097-1 10.1007/s004670050621 10.1159/000188782 10.1186/1869-5760-3-43 10.1038/ki.2014.294 10.1186/s12882-017-0747-7 10.1016/j.vetpar.2016.12.010 10.1186/1750-1172-7-57 10.1007/s00467-009-1142-9 10.1172/jci.insight.127456 10.1016/j.ajo.2003.09.040 10.1016/S0161-6420(02)00990-9 10.1093/infdis/159.4.736 10.1128/jcm.35.5.1276-1277.1997 10.1016/0140-6736(91)91064-2 10.1097/00006454-199701000-00018 10.1136/bjo.82.12.1444,1998 10.1016/s0002-9394(03)00191-0 10.1093/infdis/172.6.1561 10.3389/fcimb.2019.00408 10.3389/fvets.2019.00093 10.1086/595793 10.1016/j.exppara.2005.09.010 10.1016/s0020-7519(00)00151-x 10.2307/3284421 10.3389/fmicb.2015.00181 10.1645/GE-2453.1 10.1016/j.fawpar.2019.e00049 10.1111/jog.13638 10.2223/JPED.1948 10.1128/mSphere.00636-19 10.1016/j.diagmicrobio.2015.09.009 10.1007/s10238-003-0011-2 10.1111/j.1469-0691.2006.01444.x 10.1111/tid.12892 10.1136/archdischild-2018-316603 10.1074/mcp.M110.006916 10.1086/374647 10.1016/j.micinf.2009.07.007 10.1186/1756-3305-6-241 10.1016/S0020-7519(00)00109-0 10.1172/JCI111862 10.3389/fmicb.2015.01305
Journal of Medical Case Reports; Oya Y, Futami H et. al.

Sep 25th, 2021 - Tubulointerstitial nephritis and uveitis syndrome is a rare lymphocyte-related oculorenal inflammatory disease presumed to be associated with drug use and infectious agents. Toxoplasma gondii is one of such pathogens that could exhibit encephaliti...

Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treate...
https://doi.org/10.1007/s00296-021-04995-0 10.1016/0049-0172(73)90035-8 10.1016/j.rdc.2015.07.001 10.1016/j.semarthrit.2010.07.004 10.1007/s11910-017-0742-1 10.1038/nrneurol.2011.1 10.1038/JID.2015.350 10.1136/annrheumdis-2016-210708 10.1186/ar4582 10.1093/brain/awp289 10.1111/j.1365-2133.2008.09005.x 10.2353/ajpath.2008.070690 10.1177/135245859600100619 10.1038/nature11307 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W 10.1007/s10067-012-2113-2 10.1007/s10067-013-2419-8 10.1093/rheumatology/kes375 10.1212/WNL.47.6.1531 10.1212/WNL.53.3.457 10.1097/MD.0b013e3181441a68 10.1016/j.autrev.2009.10.003 10.1177/1352458511412996 10.1684/ejd.2015.2558 10.1016/j.jns.2006.01.012 10.1016/j.jneuroim.2021.577525 10.1177/1756286419895155 10.1097/MAJ.0b013e31822b7bb8 10.4049/jimmunol.1601532 10.1212/NXI.0000000000000076 10.1212/NXI.0000000000000183 10.3389/fneur.2018.00005 10.1056/NEJMoa1114287 10.1056/NEJMoa1206328 10.1586/14737175.2015.1025755 10.1177/1352458519828601 10.1007/s40265-014-0212-x 10.2174/1570159X14666161208151525 10.1136/annrheumdis-2012-202646 10.1056/NEJMoa1314258 10.1007/s00415-016-8128-x 10.1111/jdv.16035 10.1111/1346-8138.14619
Rheumatology International; Barešić M, Reihl Crnogaj M et. al.

Sep 25th, 2021 - Over the past two decades, tumor necrosis factor-α (TNF-α) inhibitors became one of the most important drugs in the treatment of patients with psoriatic arthritis. Unfortunately, some of the patients exhibit unwanted side effects of the treatment....

A Boy With Anterior Uveitis and Optic Disc Swelling.
https://doi.org/10.1001/jamaophthalmol.2021.1056
JAMA Ophthalmology; Luceri S, Erba S et. al.

Sep 24th, 2021 - A Boy With Anterior Uveitis and Optic Disc Swelling.|2021|Luceri S,Erba S,Casalino G,|

see more →

Guidelines  7 results

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tuber...
https://doi.org/10.1016/j.ophtha.2020.06.052
Ophthalmology Agrawal R, Testi I et. al.

Jul 1st, 2020 - The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to de...

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tuber...
https://doi.org/10.1016/j.ophtha.2020.01.008
Ophthalmology Agrawal R, Testi I et. al.

Mar 3rd, 2020 - An international, expert-led consensus initiative organized by the Collaborative Ocular Tuberculosis Study (COTS), along with the International Ocular Inflammation Society and the International Uveitis Study Group, systematically developed evidenc...

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884654
Arthritis Care & Research; Angeles-Han ST, Ringold S et. al.

Apr 26th, 2019 - To develop recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis (JIA). Pediatric rheumatologists, ophthalmologists with expertise in uveitis, patient representatives, and methodolog...

Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Ju...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261704
Arthritis Care & Research; Angeles-Han ST, Lo MS et. al.

May 29th, 2018 - Systemic immunosuppressive treatment of pediatric chronic anterior uveitis (CAU), both juvenile idiopathic arthritis-associated and idiopathic anterior uveitis, varies, making it difficult to identify best treatments. The Childhood Arthritis and R...

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveiti...
https://doi.org/10.1016/j.ophtha.2017.11.017
Ophthalmology Dick AD, Rosenbaum JT et. al.

Jan 10th, 2018 - An international, expert-led consensus initiative to develop systematic, evidence-based recommendations for the treatment of noninfectious uveitis in the era of biologics. The availability of biologic agents for the treatment of human eye disease ...

see more →

Drugs  300 results see all →

News  203 results

Risankizumab Shows Efficacy, Tolerability in Patients With PsA
https://www.medscape.com/viewarticle/952833

Jun 10th, 2021 - Risankizumab (Skyrizi) was effective for treating psoriatic arthritis (PsA) in patients who did not respond to or who could not tolerate other biologics or standard disease-modifying antirheumatic drugs (DMARDs), according to a study presented at ...

Fast Five Quiz: Ankylosing Spondylitis Management
https://reference.medscape.com/viewarticle/932595

May 27th, 2021 - Ankylosing spondylitis (AS) is a recurrent, progressive autoimmune disease that is associated with a high rate of disability. AS is characterized by inflammatory back pain, radiographic sacroiliitis, excess spinal bone formation, and a high preval...

Fast Five Quiz: Ankylosing Spondylitis Management
https://www.medscape.com/viewarticle/932595

May 27th, 2021 - Ankylosing spondylitis (AS) is a recurrent, progressive autoimmune disease that is associated with a high rate of disability. AS is characterized by inflammatory back pain, radiographic sacroiliitis, excess spinal bone formation, and a high preval...

Suspect Sarcoidosis? Here's What to Assess
https://www.medscape.com/viewarticle/948848

Apr 28th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: We are back. This is The Curbsiders. I'm Dr Matthew Watto, here with my good friend, Dr Paul Williams. We're going to talk about sarcoidosis. We had a wonderful conversation with t...

Major Advance in the Treatment of Axial Spondyloarthritis Coming
https://www.medscape.com/viewarticle/946520

Feb 26th, 2021 - Rheumatologists can look forward to the likely regulatory approval of the oral Janus kinase inhibitors tofacitinib and upadacitinib for the treatment of axial spondyloarthritis in the first half of 2021, speakers predicted at the 2021 Rheumatology...

see more →

Patient Education  1 results see all →